- Diagnostics
- Wednesday, 25 Mar 2020
Novacyt and Yourgene Healthcare companies to produce coronavirus test products in UK
Healthcare companies Novacyt and Yourgene Health Plc said on Wednesday that they would be teaming up to produce coronavirus testing products in the United Kingdom.
Yourgene’s manufacturing facility in Manchester will be used to expand Novacyt’s production capacity of the COVID-19 test.
The first batches of the critical components are expected to be shipped from the Manchester site to Novacyt’s Primerdesign unit in Southampton over the next few weeks.
“As the global demand for our COVID-19 test continues to increase, we are pleased to have rapidly established a relationship with the expert team at Yourgene to further expand our manufacturing capacity,” Novacyt CEO Graham Mullis said.
Related Industry Updates
PSA Test Explained: What It Is, How It Works, and Why It Matters
Mar 27, 2026
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)
May 26, 2020
Cytovation Announces Dosing of First Patient in its Phase I/II CICILIA Trial Investigating CyPep-1 in Patients with Solid Cancers
May 27, 2020
North America Cancer Tissue Diagnostics Market Trends, Demand, Share, Analysis To 2027 By Leading Players Bio Rad Laboratories Inc., Abbott, Enzo Life Sciences, Inc., Cancer Genetics Inc.
Dec 04, 2020
IV Equipment Market Share, Growth by Top Company, Application, Driver, Trends & Forecasts by 2027
Mar 26, 2021
China criticizes Indian to stop using Chinese coronavirus test kits
Apr 28, 2020
Mobile COVID-19 testing set for Leake and Hinds counties
May 20, 2020
Follow us on
